市場調查報告書

核酸標籤的全球市場 - 成長,趨勢,預測(2018年∼2023年)

Nucleic Acid Labeling Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 708649
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
Back to Top
核酸標籤的全球市場 - 成長,趨勢,預測(2018年∼2023年) Nucleic Acid Labeling Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

全球核酸標籤市場在2018年到2023年間,預測將以9%的年複合成長率擴大。

本報告提供核酸標籤的全球市場調查,提供市場概要,各類型,用途,各地區的市場趨勢,市場規模的變化與預測,市場促進·阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 市場方案
  • 波特的五力分析
    • 供應商談判力
    • 消費者談判力
    • 新加入廠商的威脅
    • 替代產品與服務的威脅
    • 產業內的競爭

第6章 市場動態

  • 成長要素
  • 阻礙因素
  • 市場機會
  • 課題

第7章 市場區隔

  • 標籤類別
    • 生物素系
    • 螢光
    • 放射性
    • 其他
  • 標籤技術
    • 終端標籤
    • 缺口平移
    • 隨機啟動
    • 體外轉錄
  • 各用途
    • 墨點法
    • 核酸定序
    • 光原位雜交法
    • 微陣列
    • PCR
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第8章 企業簡介

  • Enzo Biochem Inc.
  • GE Healthcare
  • Marker Gene Technologies Inc.
  • Merck KGaA
  • New England Biolabs Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • Thermo Fisher Scientific Inc.
  • Vector Laboratories Inc.

第9章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 64284

Personalized medicine aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, which has become popular in recent years. Healthcare technology, genomics involving nucleic acid labeling technology, connected devices, big data analytics, and artificial intelligence are generating vast amounts of health data and insights. This is enabling healthcare providers to offer better and faster diagnoses and make more informed treatment decisions. Rising demand for personalized medicine has created tremendous opportunities in the field of genetic medicine, and in order to exploit these opportunities, novel technologies must be developed, which, in turn, has resulted in the rapid expansion of the market. Therefore, increasing focus on personalized medicine and patient-centered approach is driving the growth of the nucleic acid labeling market.

Key Market Trends

Biotin Based Segment is Expected to Show Better Growth Over the Forecast Period

Based on label type, the market is segmented into biotin-based, fluorescent, radioactive and other label types. Non-radioactively labeled probes, such as biotin-based probes have several advantages over radioactive probes, such as increased stability and their non-hazardous nature. The biotin-based labels use non-toxic materials and have faster detection rates than radioactive probes. Furthermore, owing to their long half-life and high stability, biotin-based probes can be prepared in bulk and stored at -20°C for repeated uses. Furthermore, there have been several advancements in biotin-based techniques, such as the addition of long tails of biotinylated nucleotides through enzymatic methods to counter the technique's limitations. Pertaining to these advancements, the biotin-based label segment is expected to show better growth during the forecast period.

North America is Expected to Dominate the Nucleic Acid Labeling Market

The nucleic acid labeling market dominates the North America region due to the increasing prevalence of chronic diseases, such as cancer, aging population, growing demand for targeted and personalized medicine, and favorable government initiatives. In recent years, several government initiatives have been launched, which is supplementing the growth of the nucleic acid labeling market in the United States. For instance, in 2015, the Precision Medicine Initiative was introduced to revolutionize the treatment of chronic diseases, which has accelerated the growth of the nucleic acid labeling and its acceptance as well as adoption in the region.

Competitive Landscape

The global players into the nucleic acid labeling market are Enzo Biochem Inc., GE Healthcare, Marker Gene Technologies Inc., Merck KGaA, New England Biolabs Inc., PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific and Vector Laboratories Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Genomic and Enzymology Research
    • 4.2.2 Advancements in Tools for Synthetic Genome Design
    • 4.2.3 Growing Demand for Personalized Medicine
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
    • 4.3.2 High Cost and Complexity of Techniques
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Label Type
    • 5.1.1 Biotin-based
    • 5.1.2 Fluorescent
    • 5.1.3 Radioactive
    • 5.1.4 Other Label Types
  • 5.2 By Application
    • 5.2.1 Microarray
    • 5.2.2 DNA Sequencing
    • 5.2.3 In situ Hybridization
    • 5.2.4 Polymerase Chain Reaction
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals/Clinics
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Enzo Biochem Inc.
    • 6.1.2 GE Healthcare
    • 6.1.3 Marker Gene Technologies Inc.
    • 6.1.4 Merck KGaA
    • 6.1.5 New England Biolabs Inc.
    • 6.1.6 PerkinElmer Inc.
    • 6.1.7 Promega Corporation
    • 6.1.8 Thermo Fisher Scientific
    • 6.1.9 Vector Laboratories Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top